These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30325209)

  • 1. Incurred sample reanalysis at GSK: what have we learned?
    Summerfield SG; Barfield M; White SA
    Bioanalysis; 2018 Nov; 10(21):1755-1766. PubMed ID: 30325209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incurred sample reanalysis in AstraZeneca small molecule portfolio - what have we learned and where do we go next?
    Arfvidsson C; Wilson A; Heijer M; Bailey C; Severin P; Milligan F; Ngeny M; Dayton B; Li Y; Cape S
    Bioanalysis; 2018 Nov; 10(21):1733-1745. PubMed ID: 30325197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decade of incurred sample reanalysis: failures, investigations and impact.
    Lee LB; Wickremsinhe ER
    Bioanalysis; 2018 Nov; 10(21):1767-1772. PubMed ID: 30301360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incurred sample reproducibility: 10 years of experiences: views and recommendations from the European Bioanalysis Forum.
    Kall MA; Michi M; van der Strate B; Freisleben A; Stoellner D; Timmerman P
    Bioanalysis; 2018 Nov; 10(21):1723-1732. PubMed ID: 30412676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISR: what have we learned after a decade of experience?
    Verhaeghe T
    Bioanalysis; 2018 Nov; 10(21):1747-1753. PubMed ID: 30301364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incurred sample reanalysis: 'too much of a good thing?'.
    Fluhler EN
    Bioanalysis; 2018 Nov; 10(21):1719-1721. PubMed ID: 30301361
    [No Abstract]   [Full Text] [Related]  

  • 7. Incurred sample reanalysis in drug discovery bioanalysis.
    Giri P; Patel N; Joshi V; Giri S; Srinivas NR
    Biomed Chromatogr; 2019 Mar; 33(3):e4430. PubMed ID: 30412644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incurred sample reproducibility in pharmacokinetic bioanalysis: pros and cons from a CRO perspective.
    Timmons BM; Hay L; Gorman J; Stouffer B
    Bioanalysis; 2018 Nov; 10(21):1715-1717. PubMed ID: 30412674
    [No Abstract]   [Full Text] [Related]  

  • 9. A look back at the incurred sample reanalysis.
    Vazvaei F
    Bioanalysis; 2018 Nov; 10(21):1711-1713. PubMed ID: 30412679
    [No Abstract]   [Full Text] [Related]  

  • 10. Incurred sample reanalysis: adjusted procedure for sample size calculation.
    Rudzki PJ; Buś-Kwaśnik K; Kaza M
    Bioanalysis; 2017 Nov; 9(21):1719-1726. PubMed ID: 29120238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fit-for-Purpose Quality Control System in Continuous Bioanalysis During Long-Term Pediatric Studies.
    Ali M; Tins J; Burckhardt BB;
    AAPS J; 2019 Sep; 21(6):104. PubMed ID: 31485787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incurred sample reanalysis (ISR): a decisive tool in bioanalytical research.
    Yadav M; Shrivastav PS
    Bioanalysis; 2011 May; 3(9):1007-24. PubMed ID: 21545349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying trends and developing solutions for incurred sample reanalysis failure investigations in a bioanalytical CRO.
    Meng M; Reuschel S; Bennett P
    Bioanalysis; 2011 Feb; 3(4):449-65. PubMed ID: 21338264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of oxcarbazepine sulfate metabolite on incurred sample reanalysis and quantification of oxcarbazepine.
    Dicaire C; Bérubé ER; Dumont I; Furtado M; Garofolo F
    Bioanalysis; 2011 May; 3(9):973-82. PubMed ID: 21545345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive graphical presentation of data from incurred sample reanalysis.
    Rudzki PJ; Biecek P; Kaza M
    Bioanalysis; 2017 Jun; 9(12):947-956. PubMed ID: 28627276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incurred Sample Reanalysis: Time to Change the Sample Size Calculation?
    Rudzki PJ; Biecek P; Kaza M
    AAPS J; 2019 Feb; 21(2):28. PubMed ID: 30746568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond successful ISR: case-by-case investigations for unmatched reassay results when ISR passed.
    Tan A; Gagnon-Carignan S; Lachance S; Boudreau N; Lévesque A; Massé R
    Bioanalysis; 2011 May; 3(9):1031-8. PubMed ID: 21545351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incurred sample reproducibility.
    Vazvaei F; Timmerman P
    Bioanalysis; 2018 Nov; 10(21):1705-1706. PubMed ID: 30810353
    [No Abstract]   [Full Text] [Related]  

  • 19. Extended 3D and 4D cumulative plots for evaluation of unmatched incurred sample reanalysis.
    Rudzki PJ; Kaza M; Biecek P
    Bioanalysis; 2018 Feb; 10(3):153-162. PubMed ID: 29345502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical approaches to incurred sample LC-MS/MS reanalysis: confirming unexpected results.
    Li W; Lin H; Flarakos J; Tse FL
    Anal Chem; 2013 Feb; 85(4):2405-13. PubMed ID: 23363493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.